Similar to the previous results, BV (96.3 ± 1.1%) and LV (93.9 ± 1.2%) in the vem + pic group were notably more viable than those in other groups, owing to the effective suppression of melanoma invasion and proliferation by BRAF/PI3K combined inhibition. The gene discussed is BRAF; the disease is melanoma.